Sera from 10 healthy donors were pooled and stored at -70°C in small aliquots. Before use pooled human serum was thawed and diluted in "complete M199" without antibiotics and without newborn calf serum. Bacteria (2-5 x 108 CFU/ml) were incubated with 5% pooled human serum in M199 at 37°C in a waterbath under constant shaking (150 rpm) for 30 minutes (Marius Instruments, Utrecht, The Netherlands). After centrifugation (15 minutes, 3000 rpm, 4°C), opsonised bacteria were resuspended in M199 at a concentration of 1 x 108 CFU/ml and kept at 4°C until use.
Unopsonised bacteria were processed in the absence of serum but otherwise in the same way.
LEUCOCYTES
Polymorphonuclear neutrophils and monocytes were isolated from anticoagulated venous blood from healthy donors by dextran sedimentation of erythrocytes and differential density centrifugation on Ficoll-Isopaque gradient using a method modified from B6yum'2 as previously described.'3 Both polymorphonuclear neutrophils and mononuclear cell preparations were washed once in M199 without antibiotics, resuspended, and total cell counts were performed. The mononuclear cell fraction was also differentially counted. The final leucocyte pellets were adjusted to a concentration of 1 x 107 polymorphonuclear neutrophils or monocytes per ml. For control experiments killed polymorphonuclear neutrophils were used. Polymorphonuclear neutrophils were preincubated with 2% paraformaldehyde at room temperature for 30 minutes. After incubation cells were washed three times in M199. Peritoneal cells were isolated from peritoneal dialysis effluents from uninfected patients undergoing continuous peritoneal dialysis, as described previously. '" Briefly, cells were sedimented by centrifugation and collected in Hanks's balanced salt solution containing 0 1 % gelatin (GHBSS). Cells were then washed once in M199. Total and differential cell counts were performed. The final cell suspensions were adjusted to contain 1 x 107 peritoneal macrophages/ml of M199.
TREATMENT OF LEUCOCYTES WITH PRONASE, CYTOCHALASIN B, AND 2-DEOXY-D-GLUCOSE
To determine the nature of the interaction between polymorphonuclear neutrophils and bacteria, polymorphonuclear neutrophils were treated with pronase, cytochalasin B, or 2-deoxy-D-glucose (2d-glu). For pronase treatment, polymorphonuclear neutrophils (5 x 106/ml) were incubated with 1 mg pronase (pronase E, 70 000 PUK; Merck) per ml in Ca2+ and Mg2+ free G-HBSS for 30 minutes at 37°C. The cells were then washed and suspended in M199. For cytochalasin B or 2d-glu treatment, polymorphonuclear neutrophils were resuspended in M199 containing 5 jug of cytochalasin B (Aldrich Chemical Co, Inc, Milwaukee, Wisconsin, USA) per ml or 50 mM 2d-glu (Serva, Heidelberg, Germany) and incubated for 10 minutes at 370C before use in the phagocytosis assay. As a control, polymorphonuclear neutrophils were also preincubated with 50 mM glucose. During the assay, cytochalasin B, 2d-glu, and glucose were not removed from the medium.
SURFACE PHAGOCYTOSIS ASSAY
Surface phagocytosis assays were performed using a slightly modified version of a previously described method. remove the cell wall associated protein A S aureus Cowan I was pretreated with pronase. We also used S aureus 52A5, a teichoic acid deficient mutant of S aureus H. Phagocytosis of staphylococci was independent of proteins, including protein A, in their cell walls (table 2) ; the pronase-treated S aureus Cowan I was phagocytised as well as the untreated strain.
The presence or absence of cell wall teichoic acid did not influence the rate of phagocytosis.
To study the interaction between polymorphonuclear neutrophils and bacteria, polymorphonuclear neutrophils were treated with various inhibitors (table 3) . To examine whether the binding of the adherent S aureus to polymorphonuclear neutrophils was mediated via a pronase-sensitive receptor, polymorphonuclear neutrophils were pretreated with pronase. Pronase inactivates protein receptors, such as the C3b receptor in the membrane of the polymorphonuclear neutrophils.'6 Pronase treatment of the polymorphonuclear neutrophils significantly reduced their ability to ingest both opsonised and unopsonised S aureus Cowan I; phagocytosis was reduced by 68 and 69%, respectively (table 3). Cytochalasin B treatment of polymorphonuclear neutrophils also reduced the uptake of opsonised and unopsonised bacteria, with 46 and 37%, respectively. 2D-glu treatment of polymorphonuclear neutrophils reduced uptake to 39% for opsonised bacteria and to 30% for unopsonised bacteria compared with untreated polymorphonuclear neutrophils. Preincubation of polymorphonuclear neutrophils with glucose had no effect. phagocytised well, in contrast to peritoneal macrophages, isolated from the effluents of patients who were maintained on continuous peritoneal dialysis. Adherence of S aureus and S epidermidis to mesothelial cells was described recently.'9 We used S aureus, which was shown to adhere much better to mesothelial monolayers than S epidermidis.'9 Preopsonisation of S aureus with pooled human serum increased adherence significantly.
The positive role of a cell surface in the process of phagocytosis of unopsonised bacteria has been described previously in a model where monolayers of in vitro cultured human endothelial cells were used.20 Uptake of unopsonised staphylococci on an endothelial surface by polymorphonuclear neutrophils is only partly dependent on intact locomotion of the phagocyte.20 To determine whether intact cellular movement was important in the uptake of staphylococci from mesothelial cell surface by phagocytes, polymorphonuclear neutrophils were pretreated with 2d-glu and cytochalasin B. 2D-glu inhibits glycolysis and hexose-monophosphate shunt and therefore reduces intracellular adenosine triphosphate activity.2' Treatment of polymorphonuclear neutrophils with 2d-glu resulted in a reduction of phagocytosis of both opsonised and unopsonised S aureus CI by 40%. The effect of 2d-glu was not due to competition with glucose residues for lectin-like receptors22 as treatment of the polymorphonuclear neutrophils with 50 mM glucose had no effect. The effect of 2d-glu was comparable with that of cytochalasin B, a metabolite from the mould Helmintosporium dematioideum which interferes with the function of cytoplasmic microfilaments.23 2D-glu and cytochalasin B may act on the process of surface phagocytosis by the same mechanisminhibition of normal cellular movement of the phagocyte.
Peritoneal macrophages form an important first line of defence in the peritoneal cavity. Peritoneal macrophages from peritoneal effluents did not take up staphylococci from the mesothelial monolayer, but peritoneal macrophages do phagocytise bacteria in a suspension assay, where bacteria are presented to the phagocyte under vigorous shaking conditions.'4 These results suggest that the cellular movement of peritoneal macrophages may be defective.
To examine the possibility that attachment and ingestion of staphylococci are mediated via a protein receptor on the cell surface of the polymorphonuclear neutrophils, the polymorphonuclear neutrophils were treated with pronase. Pronase treatment of the polymorphonuclear neutrophils reduced the phagocytic capacity by 69% compared with untreated polymorphonuclear neutrophils (p < 0 001). The reduction was independent of the presence of pooled human serum. This indicates that a pronase sensitive structure is involved in the uptake of S aureus by the polymorphonuclear neutrophils on the mesothelial surface. In contrast, pronase treatment of polymorphonuclear neutrophils did not influence phagocytosis of unopsonised staphylococci on an endothelial surface. 20 These in vitro findings suggest that peritoneal macrophages may only partially contribute to the defence of the peritoneal membrane. During the initial stages of peritonitis valuable time may be lost when the microorganisms multiply freely before the arrival of phagocytes and opsonins from the circulation. We have shown that phagocytosis of staphylococci adherent to the mesothelial cell surface by peripheral blood phagocytes can proceed in the absence of opsonins. It is also known that peritoneal macrophages can phagocytise nonadherent staphylococci in suspension where their motility is not mandatory.'4 Therefore, it seems very important to investigate the reasons for the lack of motility of peritoneal macrophages. Because phagocytosis of staphylococci in suspension depends on the presence of opsonins, however, only a few bacteria might be phagocytised by peritoneal macrophages under these conditions.
The observation that incubation of mesothelial cells with radiolabelled bacteria in the absence of polymorphonuclear neutrophils resulted in a considerable amount of lysostaphinresistant mesothelial cell-associated radioactivity raises the question as to whether mesothelial cells themselves can phagocytise bacteria. Whether this is the case and what the implications of such an event would be for the pathogenic mechanism of peritonitis and antibiotic treatment is currently under study.
The assistance of R P Verkooyen in making the graphs is gratefully acknowledged. This study was supported by grant C88.0743 of the Kidney Foundation of The Netherlands.
1 Fenton SAA. Peritonitis related death among CAPD patients. Peritoneal Dial Bull 1983;3:S9-1 1.
